LIGNO Biotech’s RM60M Goal, Powered by Tiger Milk Mushrooms
Ng Szu Ting, Co-founder, LIGNO Biotech | Dr Tan Chon Seng, Co-founder, LIGNO Biotech
21-Aug-25 10:00

Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
What began as a PhD project inspired by Tun Dr. Mahathir has grown into a profitable biotech firm with over RM13 million in annual revenue. By successfully cultivating the once "uncultivatable" Tiger Milk Mushroom, Ligno Biotech has turned a Malaysian national treasure into a patented and commercial success story.
Co-founders Ng Szu Ting and Dr. Tan Chon Seng join us to share their journey from researchers to entrepreneurs. They detail how they developed their patented technology, the decade-long process of market education, and their ambitious goal to grow into a RM60 million global business.
We discuss:
The long journey of commercialising a PhD research project.
How they developed a patented cultivation technology for a "national treasure."
Their three-pronged business model combining B2B, OEM, and a house brand.
How continuous R&D serves as their key competitive advantage.
Their strategy for global expansion and the road to RM60 million in revenue.
For entrepreneurs in deep tech and biotech, this explores the long, challenging journey from lab to market.
Produced by: Roshan Kanesan, Kishan Sivaswamy
Presented by: Roshan Kanesan
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories: medical advances, entrepreneurs, SME, Corporates, technology, managing
Tags: Nutraceuticals, biotech, commercialisation, research and development, r&d grant, deep tech,